Oramed Pharmaceuticals Inc. (ORMP) is a publicly traded Healthcare sector company. As of October 2, 2026, ORMP trades at $4.52 with a market cap of $186.36M and a P/E ratio of 2.94. ORMP moved -0.22% today. Year to date, ORMP is +54.30%; over the trailing twelve months it is +78.62%. Its 52-week range spans $1.82 to $5.47. Rallies surfaces ORMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ORMP combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.52 |
| Market Cap | $186.36M |
| P/E Ratio | 2.94 |
| EPS | $1.53 |
| Dividend Yield | 0.25% |
| 52-Week High | $5.47 |
| 52-Week Low | $1.82 |
| Volume | 157.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.00M |
| Net Income | $64.02M |
| Gross Margin | 0.65% |
ORMP analyst coverage data. Average price target: $0.00.